The results of this study are particularly interesting to Cure Parkinson’s as we have been repurposing a commonly used cough medication called ambroxol for Parkinson’s. This medicine has demonstrated the ability to increase GCase levels and improve lysosome function, and rescue cells with GBA mutations. Having exhibited encouraging results in a phase 2 clinical trial, we are now in the final stages of planning a large phase 3 trial to determine if ambroxol can slow the progression of Parkinson’s.
We are sorry that this content was not useful for you
Let us improve this content
Can you tell us how we can improve this content?